FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/10/074823 [Registered on: 07/10/2024] Trial Registered Prospectively
Last Modified On: 19/09/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) [Curative]  
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Effect of Tuvarak taila cream in the management of sidhma kushtha (Pityriasis versicolor) 
Scientific Title of Study   A COMPARATIVE CLINICAL STUDY ON TUVARAK TAILA CREAM AND 2 PERCENT TOPICAL KETOCONAZOLE IN THE MANAGEMENT OF SIDHMA KUSHTHA (PITYRIASIS VERSICOLOR) IN CHILDREN- AN OPEN LABELLED RANDOMIZED CONTROLLED CLINICAL TRIAL 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Akshita Thakur 
Designation  PG SCHOLAR 
Affiliation  ALL INDIA INSTITUTE OF AYURVEDA 
Address  Room no 408 Department of Kaumarbhritya Academic block All India Institute of Ayurveda Gautampuri Sarita Vihar New Delhi 110076 South DELHI 110076 India

South
DELHI
110076
India 
Phone  9878681404  
Fax    
Email  akshitathakur084@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ved Prakash Vyas 
Designation  Professor Department of Kaumarbhritya 
Affiliation  ALL INDIA INSTITUTE OF AYURVEDA 
Address  Room no 404 Department of Kaumarbhritya Academic block All India Institute of Ayurveda Gautampuri Sarita Vihar New Delhi 110076 South DELHI 110076 India

South
DELHI
110076
India 
Phone  9907513436  
Fax    
Email  Vedvyas61@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Akshita Thakur 
Designation  PG SCHOLAR 
Affiliation  ALL INDIA INSTITUTE OF AYURVEDA 
Address  Room no 408 Department of Kaumarbhritya Academic block All India Institute of Ayurveda Gautampuri Sarita Vihar New Delhi 110076 South DELHI 110076 India

South
DELHI
110076
India 
Phone  9878681404  
Fax    
Email  akshitathakur084@gmail.com  
 
Source of Monetary or Material Support  
ALL INDIA INSTITUTE OF AYURVEDA NEW DELHI 
 
Primary Sponsor  
Name  All India Institute of Ayurveda 
Address  All India Institute of Ayurveda Gautampuri Sarita Vihar New Delhi 110076 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Akshita Thakur  All India Institute of Ayurveda  Room no 408 Department of Kaumarbhritya Academic Block All India institute of Ayurveda Gautampuri Sarita vihar New Delhi 110076 South DELHI
South
DELHI 
9878681404

akshitathakur084@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L088||Other specified local infections of the skin and subcutaneous tissue. Ayurveda Condition: SIDHMAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugOther than Classical(1) Medicine Name: Tuvaraka Taila Cream, Reference: NA, Route: Topical, Dosage Form: Malahara/ Ointment/ Balm, Dose: 10(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 3 Weeks, anupAna/sahapAna: No, Additional Information: Tuvaraka Taila Cream
2Comparator Arm (Non Ayurveda)-2% Ketoconazole CreamLocal application/Cream/Quantity Sufficient/ Frequency BD Duration 14 days
 
Inclusion Criteria  
Age From  10.00 Year(s)
Age To  16.00 Year(s)
Gender  Both 
Details  1.Patients between 10 to 16 years of age irrespective of gender.
2.Patients with clinical signs of the disease Sidhma Kushtha (Pityriasis Versicolor)-
Rajoghrishtma vimunchyati (Furferaceous scales)
Tamra Varna (Reddish black,brown coloured macules)
AlabupushpaVarna(Hypopigmentedmacules/hyperpigmented macules)
Kandu (Itching)
Urdhav kaye especially Uras (chest, trunk or neck)
Tanu (thin plaques)
3. Patients found positive for KOH test
4. Willing to give assent/consent for the trial
 
 
ExclusionCriteria 
Details  1.Children with congenital anomalies, chronic ailments such as tuberculosis, malignancy, cardiac, and renal disorders, autoimmune disorder or any other systemic illness
2.Patient have received systemic antifungal therapy within 1 month or topical antifungal therapy within 1 week of the commensal of study.
3.Patients with vitiligo, leprosy, pityriasis rosea, psoriasis, pityriasis alba, tinea capitis, tinea cruris any other skin disease
4.Parents of the patient not willing to participate in the trial
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
1 Antifungal effect of Tuvarak taila cream by performing KOH test.
2 Efficacy of Tuvarak taila cream in management of clinical features of Sidhma kushtha (pityriasis versicolor). Timeframe On 14th day/21st day (AT)and 42nd /49th day (FU). (Expected 90% improvement) and improvement in clinical features of Sidhma kushtha as per classical texts of Ayurveda
 
1 Antifungal effect of Tuvarak taila cream by performing KOH test.
2 Efficacy of Tuvarak taila cream in management of clinical features of Sidhma kushtha (pityriasis versicolor). i.e. Timeframe On 14th day/21st day (AT)and 42nd /49th day (FU). (Expected 90% improvement) and improvement in clinical features of Sidhma kushtha as per classical texts of Ayurveda
 
 
Secondary Outcome  
Outcome  TimePoints 
1.Improvement in quality of life of the child as per Children’s Dermatological Life Quality Index (CDLQI) (Expected 90% improvement)  AT (3weeks for group 1) & (2weeks for group 2) Follow Up After 4 weeks for both groups i.e.(7weeks for group 1) & (6weeks for group 2)  
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   01/05/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

RESEARCH TITLE- A comparative clinical study on Tuvarak Taila cream and 2% topical ketoconazole in the management of Sidhma kushtha (pityriasis versicolor) in children- An open labelled randomised controlled trial

RESEARCH QUESTION: - What is the effect of local application of Tuvarak taila cream in comparison to 2% topical ketoconazole in the management of Sidhma kushtha (pityriasis versicolor) in adolescent children between 10 to 16 years of age.

 

HYPOTHESIS

Local application of Tuvarak taila cream will be more effective as compared to the localapplication of 2% ketoconazole cream in the management of Sidhma kushtha (pityriasis versicolor) in adolescent children between 10 to 16 years of age.

 

NULL HYPOTHESIS

Local application of Tuvarak taila cream is equally effective as compared to the local application of 2% ketoconazole cream in the management of Sidhma kushtha (pityriasis versicolor) in adolescent children between 10 to 16 years of age.

 

ALTERNATIVE HYPOTHESIS

Local application of Tuvarak taila cream is more effective as compared to the local application of 2% ketoconazole cream in the management of Sidhma kushtha (pityriasis versicolor) in adolescent children between 10 to 16 years of age

NEED OF THE STUDY-

This disease although does not have any serious effects but have  a widespread affect on the mental health of the child. The patients of the skin diseases are prone to experience physical, emotional and socio- economic embarrassment in the society due to disfigured appearance

It significantly diminishes the confidence of adolescents, particularly given their heightened concern for appearance during this crucial developmental stage. Top of FormIt can affect the confidence and self esteem  of the child,in turn hampering the academic performance and overall development of child.Child can become isolated and withdraw themselves from social interactions and may distance themselves from peers, family members, or others in their environment. Also, persistent recurrence of tinea versicolor poses a significant challenge, necessitating the formation of other formulations to effectively address this challenge. There are very limited studies on ayurvedic intervention in Sidhma kushtha in addition to that the palatability of ayurvedic drugs in children is an immensly challenging .Thus an attempt has been made on use of Tuvarak taila cream in management of Sidhma kushtha.

OBJECTIVES

PRIMARY OBJECTIVE

·     a) To compare the efficacy of Tuvarak taila cream applied for 3 weeks and 2% topical ketoconazole cream applied for 2 weeks in the management of Sidhma Kushtha (pityriasis versicolor) based on KOH examination and to assess the improvement in clinical features of Sidhma Kushtha as per classical texts of Ayurveda.


 
Close